Stop Testing Black Babies!

PLAIN-LANGUAGE ARTICLE SUMMARY

Editorial

Editorial Highlights Structural Racism in Newborn Drug Testing, Calls for Policy Changes

Background: In this editorial, physicians trained in OB/GYN, urogynecology, medicine/pediatrics, allergy/immunology, and family medicine share their perspectives on an informative and compelling qualitative study titled, “Structural Racism in Newborn Drug Testing: Perspectives of Health Care and Child Protective Services Professionals.” The physicians, each of whom have expertise on racism, discuss the study, which examines the disproportionate use of newborn drug testing on Black newborns to detect prenatal substance abuse. 

Key Argument: The editorialists highlight that ingrained stereotypes and inconsistent hospital policies create an environment where newborn drug testing disproportionately targets Black families. They emphasize that health professionals often equate Black race with drug use during pregnancy, leading to an increase in harmful referrals to child protective services. The editorial calls for adherence to guidelines recommending questionnaires for the birthing parents instead of newborn testing. The physicians also call for the establishment of consistent policies to reduce these biases.

Why It Matters: The editorialists stress that clear, consistent policies are important to mitigate structural racism in health care. The harmful effects of biased newborn drug testing can be prevented, and trust between Black families and health systems restored by following recommended guidelines and ensuring equitable treatment. The Substance Abuse Disorder and Family Engagement (SAFE) in Recovery Act are legislative efforts highlighted as positive steps towards supporting families and reducing unnecessary separations.